Menarini International Operations Luxembourg S.A

• C01 - Terapia cardíaca
• RANEXA prolonged-release tablet 375 mg
• RANEXA prolonged-release tablet 500 mg
• RANEXA prolonged-release tablet 750 mg
• J01 - Antibacterianos para uso sistémico
• ORBACTIV powder for solution for infusion 400 mg
• L01 - Antineoplásicos
• CIAMBRA powder for solution for infusion 100 mg
• CIAMBRA powder for solution for infusion 500 mg
• N02 - Analgésicos
• SKUDEXA film-coated tablet 75 mg+25 mg
• R06 - Antihistamínicos para uso sistémico
• BILAXTEN oral solution 2.5 mg/ml
• BILAXTEN orodispersible tablet 10 mg
• BILAXTEN tablet 20 mg